Solvonis Therapeutics PLC Sustainability Reports
Solvonis Therapeutics PLC is a clinical-stage biopharmaceutical company focused on the development of novel small-molecule therapeutics for central nervous system disorders. Its primary areas of clinical focus include treatments for addiction and psychiatric conditions, such as Alcohol Use Disorder and Post-Traumatic Stress Disorder.
Sector: Manufacturing
Country: United Kingdom
Exchange: London Stock Exchange
LEI: 2138005PH7OJRCRPUD88
FIGI: BBG0147DYM99
3 reports from 2023 to 2025